港股收评：恒指跌1.34%、科指跌2.48%，科技股、芯片股及生物医药股普跌，黄金板块逆势走高

Market Overview - The Hong Kong stock market experienced fluctuations and adjustments, with the Hang Seng Index falling by 1.34% to 25,628.88 points, the Hang Seng Tech Index down 2.48% to 5,498.42 points, and the National Enterprises Index decreasing by 1.78% to 8,917.7 points [1] - Major technology stocks saw declines, including Alibaba down 3.57%, Tencent down 2.11%, and JD.com down 1.82% [1] - Semiconductor stocks also fell, with Hua Hong Semiconductor dropping over 6% and SMIC down over 4% [1] - The gold sector saw gains, with Zijin Mining up over 7% and Chifeng Jilong Gold Mining up over 5% [1] - The biopharmaceutical sector generally declined, with Baijiazheng down over 8% [1] - Insurance stocks rose collectively, supported by favorable consumption policies, with restaurant and dairy stocks performing well [1] Corporate News - China Merchants Energy (01138.HK) signed shipbuilding contracts for one ethylene ship and eighteen oil tankers, totaling RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, a year-on-year increase of 24.63% [4] - Carson International (00496.HK) entered into a steel structure procurement contract worth RMB 43.5366 million [5] Clinical and Regulatory Updates - Boke Vision Cloud-B (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Hengrui Medicine (01276) received approval for clinical trials for HRS-1780 tablets [8] - Stone Pharmaceutical Group (01093.HK) received approval for a new indication for its drug, used in first-line treatment for metastatic pancreatic cancer [6] Investment Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong market opens up space for a rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - Dongwu Securities highlighted that the main focus for Hong Kong stocks is on technology and cyclical sectors, while also paying attention to innovative drugs [13] - CITIC Securities expects the Hong Kong market to benefit from internal and external economic stimuli, predicting a sustainable upward trend in revenue and profit [13] - Dongwu Securities anticipates a continued recovery in the Hong Kong market in 2026, driven by expected interest rate cuts by the Federal Reserve and improved corporate earnings [14]